Skip Navigation


Radiation Protection Dosimetry Advance Access originally published online on September 8, 2006
Radiation Protection Dosimetry 2007 123(1):41-55; doi:10.1093/rpd/ncl083
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
123/1/41    most recent
ncl083v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kim, K. P.
Right arrow Articles by Bolch, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, K. P.
Right arrow Articles by Bolch, W. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

TENORM aerosols in the Florida phosphate industry—assessment of lung fluid solubility and annual effective dose to workers

Kwang Pyo Kim1, Chang-Yu Wu2, Brian K. Birky3 and Wesley E. Bolch1,*

1 Department of Nuclear and Radiological Engineering, University of Florida, Gainesville, FL 32611-8300, USA
2 Department of Environmental Engineering Sciences, University of Florida, Gainesville, FL 32611-8300, USA
3 Florida Institute of Phosphate Research, 1855 West Main Street, Bartow, FL 33830-7718, USA

* Corresponding author: wbolch{at}ufl.edu

Received March 11, 2006, amended May 19, 2006, accepted May 29, 2006


  Abstract

Inhalation exposure to workers in the Florida phosphate industry due to TENORM aerosols has not been adequately addressed owing to lack of aerosol information. One of the more critical factors is the absorption rate of inhaled radionuclides into blood. In this study, this parameter was characterised using an in vitro dissolution test. The solubility data and other aerosol information were then used for individualised dose assessments at six different Florida phosphate facilities. The solubility data support the selections of ICRP Publication 66 Type M for uranium and lead isotopes and Type S for thorium isotopes. Total annual effective doses are 0.34 ± 0.12 mSv at granulator areas, 0.30 ± 0.10 mSv at storage areas and 0.23 ± 0.02 mSv at shipping areas. These findings are considerably lower than originally postulated in previous studies where no site-specific information on particle size and lung fluid solubility had been available.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.